Sevelamer Carbonate Tablet, Film Coated
Product Images NDC 69367-423

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Sevelamer Carbonate (NDC 69367-423). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Westminster Pharmaceuticals, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Sevelamer 01)

Chemical structure diagram of Sevelamer Carbonate, showing polymeric components with ammonium and hydroxyl functional groups and bicarbonate ion (HCO3-) interactions, consistent with its polymeric pharmaceutical composition.*

FDA Label Image

Chemical Structure (Sevelamer 02)

A forest plot showing subgroup analyses comparing Sevelamer Carbonate versus placebo across various patient groups. The x-axis represents the mean difference favoring either Sevelamer Carbonate or placebo. Subgroups analyzed include overall population, screening BSA (<1.2 and ≥1.2 m²), baseline serum phosphorus (<7 and ≥7 mg/dL), age (<13 and ≥13 years), and dialysis status (yes or no). The chart depicts confidence intervals and mean differences for each subgroup.*

FDA Label Image

Chemical Structure (Sevelamer 03)

A line graph showing the percentage of patients with reductions in serum phosphorus levels (mg/dL) on the x-axis and the corresponding percentage of patients achieving at least that reduction on the y-axis. The graph compares Sevelamer Hydrochloride with an active control in terms of phosphorus reduction efficacy.*

FDA Label Image

Chemical Structure (Sevelamer 04)

A line graph depicting phosphorus change from baseline over a 52-week study period. The x-axis represents study weeks from 0 to 52, and the y-axis shows phosphorus change ranging from -5 to 2. Two treatment groups are shown: Sevelamer Hydrochloride and an Active-Control, with Sevelamer Hydrochloride generally maintaining a greater decrease in phosphorus levels over time.*

FDA Label Image

Principal Display Panel (800 mg Tablet Bottle Label)

Label for Sevelamer Carbonate Tablets 800 mg oral film-coated tablets. The label indicates a bottle containing 270 tablets. Manufactured for Westminster Pharmaceuticals, LLC, the label also includes storage instructions and a barcode with NDC 69367-423-27.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.